Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
The agency is expected to rule Tuesday on what’s come to be called Viagra for women.
Viagra is one of the most-counterfeited drugs on the web, and Pfizer's latest effort to tackle that issue is a first.
